News


IXICO webinar session;
Using MRI to assess safety, efficacy and eligibility of new Alzheimer's Disease therapies. This Webinar is now over. “We were overwhelmed with the turnout and level of participation”.Ciaran Cooper. VP Business Development.
A re-run of this session will be announced soon.
For more information  Click here

ISO 9001 Certified

Trial Tracker

The success of an imaging trial or research study often depends on the project team’s ability to see the data as it is collected and correct course as needed to ensure that good quality data is collected on time, every time.

Trial Tracker is IXICO’s web-based image management system for comprehensive management of all imaging data from acquisition to analysis. Trial Tracker provides real-time viewing of image data from your research study or clinical trial. It can hold information from multiple studies for cross-trial comparisons and meta-analyses. Trial Tracker operates through a central database with a web-based interface for upload and download of data with trial site information, as well as subject and timepoint views with real-time status updates. All members of your research team, wherever they are in the world, can interact with the same portal using role-based user access set by the study administrator.

Real-time data tracking

  • avoid costly delays
  • identify underperforming sites
  • manage your projects efficiently

Integrated QC with protocol-specific checks

  • increase protocol compliance
  • add to the statistical power of data
  • decrease study close-out times
  • catch errors in time to maintain study timelines
  • avoid lost or unusable data

Global access

  • increased efficiency
  • improved communication
  • ease-of-use

The goal is better data faster. The requirement is control. The key is access anywhere, anytime.

The answer is Trial Tracker.

 

"Working with our customers, we can unlock imaging's potential to accelerate and reduce the costs of product development, and hence give more patients earlier access to effective and safe treatments."

Prof Derek Hill,
CEO, IXICO

New article

Expert Opinion on Investigational Drugs - by Derek Hill, CEO

The North American Alzheimer's Disease Neuroimaging Initiative, and similar activities in Europe, Japan, and Australia, are natural history studies that are providing new insights into the use of imaging end points in clinical trials. See the article here.